semaglutide patent expiry india in spurs generic drug boom Ozempic In India Soon? Novo
Description
Methods Arm-level data from phase III randomized controlled trials of semaglutide (SUSTAIN, STEP) and tirzepatide (SURPASS, SURMOUNT-2) in T2DM were analyzed
It's a cardiovascular efficiency story, not a metabolic one
Learn more and see if you should add it to your stac
Medicare Part D plans can now cover the popular weight loss drug for patients who are prescribed the medication to reduce the risk of serious heart events
But with it comes the risk of a race to the bottom
Breaking data at ADA 2024: results from the first dedicated kidney outcomes trial with a GLP-1RA.
